Cargando…
Targeted activation of AMPK by GSK621 ameliorates H(2)O(2)-induced damages in osteoblasts
GSK621 is a novel AMP-activated protein kinase (AMPK) activator. This study tested its potential cytoprotective effect in hydrogen peroxide (H(2)O(2))-treated osteoblasts. In cultured MC3T3-E1 osteoblastic cells and primary murine osteoblasts, GSK621 significantly attenuated H(2)O(2)-induced cell de...
Autores principales: | Liu, Weidong, Mao, Li, Ji, Feng, Chen, Fengli, Hao, Yuedong, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354679/ https://www.ncbi.nlm.nih.gov/pubmed/28060740 http://dx.doi.org/10.18632/oncotarget.14454 |
Ejemplares similares
-
GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings
por: Jiang, Hong, et al.
Publicado: (2016) -
Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone
por: Liu, Weidong, et al.
Publicado: (2016) -
RNAseq analysis of α-proteobacterium Gluconobacter oxydans 621H
por: Kranz, Angela, et al.
Publicado: (2018) -
The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho–Ser-621 in the C terminus of CRAF
por: Yuan, Jimin, et al.
Publicado: (2018) -
Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis
por: Lv, Hongming, et al.
Publicado: (2017)